Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organ-sparing strategy for locally advanced rectal cancer using electrochemotherapy after neoadjuvant treatment
2018-004166-33Phase 2Active
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bleomycin in rectal cancer (2 arms), sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Primary endpoint: Complete pathological response rate. Started Dec 2018; status: active.
02
Drugs
bleomycin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on 2018-004166-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004166-33.